SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013018
Filing Date
2022-08-10
Accepted
2022-08-10 13:33:31
Documents
49
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220630x10q.htm   iXBRL 10-Q 963768
2 EX-31.1 tmb-20220630xex31d1.htm EX-31.1 16235
3 EX-31.2 tmb-20220630xex31d2.htm EX-31.2 16221
4 EX-32.1 tmb-20220630xex32d1.htm EX-32.1 8746
5 EX-32.2 tmb-20220630xex32d2.htm EX-32.2 8521
  Complete submission text file 0001558370-22-013018.txt   3915497

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220630.xsd EX-101.SCH 25987
7 EX-101.CAL tmb-20220630_cal.xml EX-101.CAL 16837
8 EX-101.DEF tmb-20220630_def.xml EX-101.DEF 125009
9 EX-101.LAB tmb-20220630_lab.xml EX-101.LAB 261882
10 EX-101.PRE tmb-20220630_pre.xml EX-101.PRE 223887
43 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220630x10q_htm.xml XML 561211
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41264 | Film No.: 221151264
SIC: 2834 Pharmaceutical Preparations